The aim of the study was to survey the development of distinctive parameters of speech and non-speech vocal performance in the time course of premanifest Huntington's disease (HD). Methods We examined 13 speakers with premanifest HD which were tested and re-tested after 22 months using a speech task consisting of a) reading a German text (for the calculation of net speech rate/NSR and pause ratio/PR%) and b) several subtests for the monitoring of non-speech vocal performance to calculate the maximum syllable repetition capacity/maxSylRep and the precision of syllable in a self-chosen steady pace (the coefficient of variance/COV displayed the steadiness of repetition). Results Disease specific variables as overall motor impairment and the cognitive score became worse over time. Furthermore, in the speech tasks, there was a tendency to a reduction of NSR and maxSylRep and further decline of the steadiness of syllable repetition. The self-chosen pace of syllable repetition was significantly slower at follow-up (p < 0.0001). Moreover, there was a correlation between the reduction of the MRI based volume of the caudate nucleus and a worsening of syllable repetition over time.Conclusions Abnormalities of speech rate and rhythm are detectable even in the premanifest stages of HD and show a tendency to further deteriorate in the time course of disease progression. Further long-term follow-up studies are warranted to survey the evolution of these distinctive patterns with time which might be helpful for the monitoring of disease progression and could provide some further insight into the underlying pathophysiology of HD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.